Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Receivables (2020 - 2026)

SkinHealth Systems has reported Receivables over the past 6 years, most recently at $21.7 million for Q4 2025.

  • Quarterly Receivables fell 24.1% to $21.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.7 million through Dec 2025, down 24.1% year-over-year, with the annual reading at $21.7 million for FY2025, 24.1% down from the prior year.
  • Receivables was $21.7 million for Q4 2025 at SkinHealth Systems, down from $22.2 million in the prior quarter.
  • Over five years, Receivables peaked at $84.0 million in Q3 2022 and troughed at $21.7 million in Q4 2025.
  • The 5-year median for Receivables is $50.4 million (2024), against an average of $51.9 million.
  • Year-over-year, Receivables soared 150.81% in 2021 and then tumbled 61.02% in 2025.
  • A 5-year view of Receivables shows it stood at $47.2 million in 2021, then soared by 74.71% to $82.5 million in 2022, then dropped by 15.51% to $69.7 million in 2023, then plummeted by 58.9% to $28.6 million in 2024, then fell by 24.1% to $21.7 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Receivables are $21.7 million (Q4 2025), $22.2 million (Q3 2025), and $25.0 million (Q2 2025).